Cite
MLA Citation
Daniel J. George et al.. “Number needed to harm (NNH) in patients with non-metastatic, castration-resistant prostate cancer (nmCRPC): A final analysis from the darolutamide (D), enzalutamide (E), and apalutamide (A) clinical trials..” Journal of clinical oncology, vol. 40, no. 28, n.d., p. 326. http://access.bl.uk/ark:/81055/vdc_100169171536.0x000022